Mice expressing mutant amyloid precursor protein (APP) or tau do not present significant neuronal loss; therefore, it has been theorised that the addition of the inflammatory component of AD would result in a more appropriate model to investigate the disease. This evidence concerns the gene MAPT and Alzheimer disease.